Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor necrosis factor receptor 1 (TNFR1) is a ubiquitous membrane protein that serves as a primary mediator for the biological effects of tumor necrosis factor (TNF). Historically identified in early binding studies as high-affinity cell surface binding sites on various cell lines, including HeLa cells, TNFR1 is characterized by its ability to trigger both pro-inflammatory gene expression and programmed cell death (apoptosis). Upon binding to TNF, the receptor recruits intracellular adapter proteins to its death domain, initiating signaling cascades such as the NF-kappaB and MAPK pathways. In disease states, overactivation of TNFR1 signaling is a hallmark of chronic inflammatory conditions like rheumatoid arthritis and Crohn's disease, making it a critical therapeutic target. Modern biologics, including monoclonal antibodies and soluble receptor decoys, effectively manage these diseases by preventing the interaction between TNF and its high-affinity receptors.
Inhibition of tumor necrosis factor (TNF) binding to its receptors, thereby neutralizing its pro-inflammatory and apoptotic signaling effects.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor necrosis factor receptor 1 (TNFR1) (TNFR1).